Congratulations to Dr. Darlene Dai, Dr. Stuart Turvey and Dr. Charisse Petersen on the study!
@turveylab.bsky.social
Posts by Turvey Lab
New research from BCCHR, uses longitudinal data from the CHILD Cohort Study, to show that breastfeeding acts as a shield, protecting the infant microbiota from many different exposures well into early childhood. The impact is especially clear among children from lower socioeconomic status.
I totally agree. It is my mission to always connect with bedside care teams rather than hiding away on my computer. This is where I find the joy of medicine! But maybe I am just old?
Thanks Dawn!
Our new paper is out!
Online now: Breastfeeding may lessen socioeconomic disparities in child health through differences in the infant gut microbiome
Thanks for noticing @labwaggoner.bsky.social !
Breastfeeding may lessen socioeconomic disparities in child health through differences in the infant gut microbiome @cp-cellrepmed.bsky.social @turveylab.bsky.social
@bcchresearch.bsky.social
www.cell.com/cell-reports...
Totally agree with this!
Bravo! Really important work.
Monogenic disorders of the IRF transcription factors. Review by Mattison Stojcic, Pariya Yousefi, Catherine Biggs, and Stuart Turvey @turveylab.bsky.social: rupress.org/jem/article/...
📘 In our #InnateImmunity collection: rupress.org/jem/collecti...
#KSInnateImmune26
You are kind to say that Dawn!
Fantastic interview with Ty Sperle and BCCHR's Dr Stuart Turvey (@turveylab.bsky.social) on a successful gene treatment for a rare immune disorder on The Current with Matt Galloway this morning.
www.cbc.ca/listen/live-...
Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.
In a world first, B.C. teen cured of rare disease through gene editing treatment. Ty Sperle cured of chronic granulomatous disease with a treatment known as “prime editing,” by Brenna Owen www.theglobeandmail.com/canada/briti... via @theglobeandmail.com
Great to talk with Matt Galloway on CBC The Current this morning about successful gene therapy for a human immune defect.
The Current with Matt Galloway - March 9, 2026: How a gene edit gave a B.C teen his life back.
www.cbc.ca/listen/live-...
@mattgalloway.bsky.social @bcchresearch.bsky.social
Learn how the early life #microbiome shapes immune programming in childhood #asthma and #allergies in this review from Stuart Turvey and colleagues mucosalimmunology.org/article/S193...
A multimorphic variant in ThPOK causes #InbornErrorsOfImmunity with T cell defects and #fibrosis, say Maryam Vaseghi-Shanjani, Mehul Sharma, Catherine M. Biggs, Stuart E. Turvey et al. @TurveyLab.bsky.social
rupress.org/jem/article/...
Instead of studying asthma only after children get sick, Dr. Stuart Turvey and his team at UBC have taken a different approach.
💩 By analyzing infant stool samples, researchers found differences in gut bacteria that were associated with later development of #asthma: https://bit.ly/4rqPbHa
@romberglab.bsky.social!!
What can dirty diapers tell us about #asthma?
Clues from the gut #microbiome are reshaping how we understand pediatric asthma and allergies!
Breastfeeding, B. infantis, and early microbial exposures matter. 2025 @washumedicine.bsky.social Pediatric
Research Retreat #Keynote by Stuart Turvey
B.C. man cured of rare disease in world-first for new gene-editing technology
https://www.newsbeep.com/ca/500965/
Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through…
This is BRILLIANT!!
B.C. teen becomes first in the world cured of rare disease using gene editing 🙏
18-year-old Ty Sperle from UBC Okanagan was Participant 1 in the trial. He had chronic granulomatous disease since age 5 and is now completely cured after the gene edit fixed his immune cells.
B.C. man cured of rare disease in world-first for new gene-editing technology - Ty Sperle says he felt “insane shock” after learning he’d been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.
Ultimate precision medicine!
Delighted to have played a small part to ensure our patient from @bcchresearch.bsky.social was able to receive this remarkable curative treatment.
Kudos to Dr. Elie Haddad for launching this trial in Canada.
@nejm.org @genomecanada.ca @genomebc.bsky.social
Ty Sperle says he felt "insane shock" after learning he'd been cured of a rare genetic disease through a clinical trial using a new gene-editing treatment.
Ultimate precision medicine!
Delighted to have played a small part to ensure our patient from @bcchresearch.bsky.social was able to receive this remarkable curative treatment.
Kudos to Dr. Elie Haddad for launching this trial in Canada.
@nejm.org @genomecanada.ca @genomebc.bsky.social
Ultimate precision medicine!
Delighted to have played a small part to ensure our patient from @bcchresearch.bsky.social was able to receive this remarkable curative treatment.
Kudos to Dr. Elie Haddad for launching this trial in Canada.
@nejm.org @genomecanada.ca @genomebc.bsky.social
#5 Kanegane et al review unresolved issues in the pathogenesis of X-linked agammaglobulinemia (XLA), incl. non-coding BTK variants, contiguous deletion syndrome, Helicobacter infection, non-infectious neurodegeneration, renal involvement & malignancies: rupress.org/jhi/article/...
#4 Type I IFN autoantibodies (auto-Abs) are associated w/ severe #COVID19. Peduti et al. reveal a 6.7% prevalence of auto-Abs in critically ill Brazilian patients, predominantly affecting older individuals, and links their presence to worse clinical outcomes: rupress.org/jhi/article/...